Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization

Erin E. Kohler, Jugajyoti Baruah, Norifumi Urao, Masuko Ushio-Fukai, Tohru Fukai, Ishita Chatterjee, Kishore K. Wary

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Endothelial cell (EC) dedifferentiation in relation to neovascularization is a poorly understood process. In this report, we addressed the role of Wnt signaling in the mechanisms of neovascularization in adult tissues. Here, we show that a low-dose of 6-bromoindirubin-3′-oxime (BIO), a competitive inhibitor of glycogen synthase kinase-3β, induced the stabilization of β-catenin and its subsequent direct interaction with the transcription factor NANOG in the nucleus of ECs. This event induced loss of VE-cadherin from the adherens junctions, increased EC proliferation accompanied by asymmetric cell division (ACD), and formed cellular aggregates in hanging drop assays indicating the acquisition of a dedifferentiated state. In a chromatin immunoprecipitation assay, nuclear NANOG protein bound to the NANOG- and VEGFR2-promoters in ECs, and the addition of BIO activated the NANOG-promoter-luciferase reporter system in a cell-based assay. Consequently, NANOG-knockdown decreased BIO-induced NOTCH-1 expression, thereby decreasing cell proliferation, ACD, and neovascularization. In a Matrigel plug assay, BIO induced increased neovascularization, secondary to the presence of vascular endothelial growth factor (VEGF). Moreover, in a mouse model of hind limb ischemia, BIO augmented neovascularization that was coupled with increased expression of NOTCH-1 in ECs and increased smooth muscle α-actin + cell recruitment around the neovessels. Thus, these results demonstrate the ability of a low-dose of BIO to augment neovascularization secondary to VEGF, a process that was accompanied by a partial dedifferentiation of ECs via β-catenin and the NANOG signaling pathway. Stem Cells 2014;32:1538-1552

Original languageEnglish (US)
Pages (from-to)1538-1552
Number of pages15
JournalStem Cells
Volume32
Issue number6
DOIs
StatePublished - Jun 2014

Fingerprint

Oximes
Endothelial Cells
Asymmetric Cell Division
Catenins
Vascular Endothelial Growth Factor A
Cell Dedifferentiation
Cell Proliferation
Glycogen Synthase Kinase 3
Adherens Junctions
Chromatin Immunoprecipitation
Nuclear Proteins
Luciferases
Smooth Muscle Myocytes
Actins
Transcription Factors
Stem Cells
Ischemia
Extremities
6-bromoindirubin-3'-oxime

Keywords

  • 6-Bromoindirubin-3′-oxime
  • Dedifferentiation
  • Endothelial cells
  • Hind limb ischemia
  • Neovascularization

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this

Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization. / Kohler, Erin E.; Baruah, Jugajyoti; Urao, Norifumi; Ushio-Fukai, Masuko; Fukai, Tohru; Chatterjee, Ishita; Wary, Kishore K.

In: Stem Cells, Vol. 32, No. 6, 06.2014, p. 1538-1552.

Research output: Contribution to journalArticle

Kohler, Erin E. ; Baruah, Jugajyoti ; Urao, Norifumi ; Ushio-Fukai, Masuko ; Fukai, Tohru ; Chatterjee, Ishita ; Wary, Kishore K. / Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization. In: Stem Cells. 2014 ; Vol. 32, No. 6. pp. 1538-1552.
@article{97bc99ea497a4045baaa31872535f287,
title = "Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization",
abstract = "Endothelial cell (EC) dedifferentiation in relation to neovascularization is a poorly understood process. In this report, we addressed the role of Wnt signaling in the mechanisms of neovascularization in adult tissues. Here, we show that a low-dose of 6-bromoindirubin-3′-oxime (BIO), a competitive inhibitor of glycogen synthase kinase-3β, induced the stabilization of β-catenin and its subsequent direct interaction with the transcription factor NANOG in the nucleus of ECs. This event induced loss of VE-cadherin from the adherens junctions, increased EC proliferation accompanied by asymmetric cell division (ACD), and formed cellular aggregates in hanging drop assays indicating the acquisition of a dedifferentiated state. In a chromatin immunoprecipitation assay, nuclear NANOG protein bound to the NANOG- and VEGFR2-promoters in ECs, and the addition of BIO activated the NANOG-promoter-luciferase reporter system in a cell-based assay. Consequently, NANOG-knockdown decreased BIO-induced NOTCH-1 expression, thereby decreasing cell proliferation, ACD, and neovascularization. In a Matrigel plug assay, BIO induced increased neovascularization, secondary to the presence of vascular endothelial growth factor (VEGF). Moreover, in a mouse model of hind limb ischemia, BIO augmented neovascularization that was coupled with increased expression of NOTCH-1 in ECs and increased smooth muscle α-actin + cell recruitment around the neovessels. Thus, these results demonstrate the ability of a low-dose of BIO to augment neovascularization secondary to VEGF, a process that was accompanied by a partial dedifferentiation of ECs via β-catenin and the NANOG signaling pathway. Stem Cells 2014;32:1538-1552",
keywords = "6-Bromoindirubin-3′-oxime, Dedifferentiation, Endothelial cells, Hind limb ischemia, Neovascularization",
author = "Kohler, {Erin E.} and Jugajyoti Baruah and Norifumi Urao and Masuko Ushio-Fukai and Tohru Fukai and Ishita Chatterjee and Wary, {Kishore K.}",
year = "2014",
month = "6",
doi = "10.1002/stem.1658",
language = "English (US)",
volume = "32",
pages = "1538--1552",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "6",

}

TY - JOUR

T1 - Low-dose 6-bromoindirubin-3′-oxime induces partial dedifferentiation of endothelial cells to promote increased neovascularization

AU - Kohler, Erin E.

AU - Baruah, Jugajyoti

AU - Urao, Norifumi

AU - Ushio-Fukai, Masuko

AU - Fukai, Tohru

AU - Chatterjee, Ishita

AU - Wary, Kishore K.

PY - 2014/6

Y1 - 2014/6

N2 - Endothelial cell (EC) dedifferentiation in relation to neovascularization is a poorly understood process. In this report, we addressed the role of Wnt signaling in the mechanisms of neovascularization in adult tissues. Here, we show that a low-dose of 6-bromoindirubin-3′-oxime (BIO), a competitive inhibitor of glycogen synthase kinase-3β, induced the stabilization of β-catenin and its subsequent direct interaction with the transcription factor NANOG in the nucleus of ECs. This event induced loss of VE-cadherin from the adherens junctions, increased EC proliferation accompanied by asymmetric cell division (ACD), and formed cellular aggregates in hanging drop assays indicating the acquisition of a dedifferentiated state. In a chromatin immunoprecipitation assay, nuclear NANOG protein bound to the NANOG- and VEGFR2-promoters in ECs, and the addition of BIO activated the NANOG-promoter-luciferase reporter system in a cell-based assay. Consequently, NANOG-knockdown decreased BIO-induced NOTCH-1 expression, thereby decreasing cell proliferation, ACD, and neovascularization. In a Matrigel plug assay, BIO induced increased neovascularization, secondary to the presence of vascular endothelial growth factor (VEGF). Moreover, in a mouse model of hind limb ischemia, BIO augmented neovascularization that was coupled with increased expression of NOTCH-1 in ECs and increased smooth muscle α-actin + cell recruitment around the neovessels. Thus, these results demonstrate the ability of a low-dose of BIO to augment neovascularization secondary to VEGF, a process that was accompanied by a partial dedifferentiation of ECs via β-catenin and the NANOG signaling pathway. Stem Cells 2014;32:1538-1552

AB - Endothelial cell (EC) dedifferentiation in relation to neovascularization is a poorly understood process. In this report, we addressed the role of Wnt signaling in the mechanisms of neovascularization in adult tissues. Here, we show that a low-dose of 6-bromoindirubin-3′-oxime (BIO), a competitive inhibitor of glycogen synthase kinase-3β, induced the stabilization of β-catenin and its subsequent direct interaction with the transcription factor NANOG in the nucleus of ECs. This event induced loss of VE-cadherin from the adherens junctions, increased EC proliferation accompanied by asymmetric cell division (ACD), and formed cellular aggregates in hanging drop assays indicating the acquisition of a dedifferentiated state. In a chromatin immunoprecipitation assay, nuclear NANOG protein bound to the NANOG- and VEGFR2-promoters in ECs, and the addition of BIO activated the NANOG-promoter-luciferase reporter system in a cell-based assay. Consequently, NANOG-knockdown decreased BIO-induced NOTCH-1 expression, thereby decreasing cell proliferation, ACD, and neovascularization. In a Matrigel plug assay, BIO induced increased neovascularization, secondary to the presence of vascular endothelial growth factor (VEGF). Moreover, in a mouse model of hind limb ischemia, BIO augmented neovascularization that was coupled with increased expression of NOTCH-1 in ECs and increased smooth muscle α-actin + cell recruitment around the neovessels. Thus, these results demonstrate the ability of a low-dose of BIO to augment neovascularization secondary to VEGF, a process that was accompanied by a partial dedifferentiation of ECs via β-catenin and the NANOG signaling pathway. Stem Cells 2014;32:1538-1552

KW - 6-Bromoindirubin-3′-oxime

KW - Dedifferentiation

KW - Endothelial cells

KW - Hind limb ischemia

KW - Neovascularization

UR - http://www.scopus.com/inward/record.url?scp=84901419136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901419136&partnerID=8YFLogxK

U2 - 10.1002/stem.1658

DO - 10.1002/stem.1658

M3 - Article

C2 - 24496925

AN - SCOPUS:84901419136

VL - 32

SP - 1538

EP - 1552

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 6

ER -